context stringlengths 21 24.6k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 168 |
|---|---|---|---|---|---|
On November 28, 2023, IQVIA Inc. (the “Issuer”), completed the issuance and sale of $ 1,250 million in gross proceeds of 6.250 % senior secured notes due 2029 (the “2029 Senior Secured Notes”). The 2029 Senior Secured Notes were issued pursuant to an Indenture, dated November 28, 2023, among the Issuer, U.S. Bank Trust... | text | 1250 | monetaryItemType | text: <entity> 1250 </entity> <entity type> monetaryItemType </entity type> <context> On November 28, 2023, IQVIA Inc. (the “Issuer”), completed the issuance and sale of $ 1,250 million in gross proceeds of 6.250 % senior secured notes due 2029 (the “2029 Senior Secured Notes”). The 2029 Senior Secured Notes were issue... | us-gaap:DebtInstrumentCarryingAmount |
On November 28, 2023, IQVIA Inc. (the “Issuer”), completed the issuance and sale of $ 1,250 million in gross proceeds of 6.250 % senior secured notes due 2029 (the “2029 Senior Secured Notes”). The 2029 Senior Secured Notes were issued pursuant to an Indenture, dated November 28, 2023, among the Issuer, U.S. Bank Trust... | text | 6.250 | percentItemType | text: <entity> 6.250 </entity> <entity type> percentItemType </entity type> <context> On November 28, 2023, IQVIA Inc. (the “Issuer”), completed the issuance and sale of $ 1,250 million in gross proceeds of 6.250 % senior secured notes due 2029 (the “2029 Senior Secured Notes”). The 2029 Senior Secured Notes were issue... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The 2029 Senior Secured Notes are secured obligations of the Company, will mature on February 1, 2029, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.250 % per year, with interest payable semi-annually on February 1 and August 1 of each year, beginning on Febru... | text | 6.250 | percentItemType | text: <entity> 6.250 </entity> <entity type> percentItemType </entity type> <context> The 2029 Senior Secured Notes are secured obligations of the Company, will mature on February 1, 2029, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.250 % per year, with inte... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 750 million in gross proceeds of 5.700 % senior secured notes due 2028 (the “2028 Senior Secured Notes”). The 2028 Senior Secured Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, Nat... | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 750 million in gross proceeds of 5.700 % senior secured notes due 2028 (the “2028 Senior Secured Notes”). The 2028 Senior Secured Notes were issued pursuan... | us-gaap:DebtInstrumentCarryingAmount |
On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 750 million in gross proceeds of 5.700 % senior secured notes due 2028 (the “2028 Senior Secured Notes”). The 2028 Senior Secured Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, Nat... | text | 5.700 | percentItemType | text: <entity> 5.700 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 750 million in gross proceeds of 5.700 % senior secured notes due 2028 (the “2028 Senior Secured Notes”). The 2028 Senior Secured Notes were issued pursua... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The 2028 Senior Secured Notes are secured obligations of the Company, will mature on May 15, 2028, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 5.700 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 1... | text | 5.700 | percentItemType | text: <entity> 5.700 </entity> <entity type> percentItemType </entity type> <context> The 2028 Senior Secured Notes are secured obligations of the Company, will mature on May 15, 2028, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 5.700 % per year, with interest... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 register... | text | 1250 | monetaryItemType | text: <entity> 1250 </entity> <entity type> monetaryItemType </entity type> <context> In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 75... | us-gaap:DebtInstrumentCarryingAmount |
In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 register... | text | 6.250 | percentItemType | text: <entity> 6.250 </entity> <entity type> percentItemType </entity type> <context> In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 75... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 register... | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750... | us-gaap:DebtInstrumentCarryingAmount |
In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 register... | text | 5.700 | percentItemType | text: <entity> 5.700 </entity> <entity type> percentItemType </entity type> <context> In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 75... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 500 million in gross proceeds of 6.500 % senior notes due 2030 (the “2030 Senior Notes”). The 2030 Senior Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as tr... | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 500 million in gross proceeds of 6.500 % senior notes due 2030 (the “2030 Senior Notes”). The 2030 Senior Notes were issued pursuant to an Indenture, dated... | us-gaap:DebtInstrumentCarryingAmount |
On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 500 million in gross proceeds of 6.500 % senior notes due 2030 (the “2030 Senior Notes”). The 2030 Senior Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as tr... | text | 6.500 | percentItemType | text: <entity> 6.500 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 500 million in gross proceeds of 6.500 % senior notes due 2030 (the “2030 Senior Notes”). The 2030 Senior Notes were issued pursuant to an Indenture, date... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 202... | text | 6.500 | percentItemType | text: <entity> 6.500 </entity> <entity type> percentItemType </entity type> <context> The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payab... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 202... | text | 3.250 | percentItemType | text: <entity> 3.250 </entity> <entity type> percentItemType </entity type> <context> The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payab... | us-gaap:DebtInstrumentRedemptionPricePercentage |
The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 202... | text | 0.000 | percentItemType | text: <entity> 0.000 </entity> <entity type> percentItemType </entity type> <context> The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payab... | us-gaap:DebtInstrumentRedemptionPricePercentage |
On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are sold on a non-recourse basis by certain of the Company's consolidated subsidiaries (e... | text | 550 | monetaryItemType | text: <entity> 550 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are ... | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are sold on a non-recourse basis by certain of the Company's consolidated subsidiaries (e... | text | 440 | monetaryItemType | text: <entity> 440 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are ... | us-gaap:LineOfCredit |
On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are sold on a non-recourse basis by certain of the Company's consolidated subsidiaries (e... | text | 110 | monetaryItemType | text: <entity> 110 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are ... | us-gaap:LineOfCredit |
On January 10, 2017, Quintiles IMS Health Incorporated and IMS Software Services Ltd. (collectively “IQVIA Parties”), filed a lawsuit in the U.S. District Court for the District of New Jersey against Veeva Systems, Inc. (“Veeva”) alleging Veeva unlawfully used IQVIA Parties intellectual property to improve Veeva data o... | text | 200 | monetaryItemType | text: <entity> 200 </entity> <entity type> monetaryItemType </entity type> <context> On January 10, 2017, Quintiles IMS Health Incorporated and IMS Software Services Ltd. (collectively “IQVIA Parties”), filed a lawsuit in the U.S. District Court for the District of New Jersey against Veeva Systems, Inc. (“Veeva”) alleg... | us-gaap:LossContingencyDamagesSoughtValue |
The Company is authorized to issue 1.0 million shares of preferred stock, $ 0.01 per share par value. No shares of preferred stock were issued and outstanding as of December 31, 2024 or 2023. | text | 1.0 | sharesItemType | text: <entity> 1.0 </entity> <entity type> sharesItemType </entity type> <context> The Company is authorized to issue 1.0 million shares of preferred stock, $ 0.01 per share par value. No shares of preferred stock were issued and outstanding as of December 31, 2024 or 2023. </context> | us-gaap:PreferredStockSharesAuthorized |
The Company is authorized to issue 1.0 million shares of preferred stock, $ 0.01 per share par value. No shares of preferred stock were issued and outstanding as of December 31, 2024 or 2023. | text | 0.01 | perShareItemType | text: <entity> 0.01 </entity> <entity type> perShareItemType </entity type> <context> The Company is authorized to issue 1.0 million shares of preferred stock, $ 0.01 per share par value. No shares of preferred stock were issued and outstanding as of December 31, 2024 or 2023. </context> | us-gaap:PreferredStockParOrStatedValuePerShare |
As of December 31, 2024, the Company had remaining authorization to repurchase up to $ 1,013 million of its common stock under the Repurchase Program. In addition, from time to time, the Company has repurchased and may continue to repurchase common stock through private or other transactions outside of the Repurchase P... | text | 1013 | monetaryItemType | text: <entity> 1013 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had remaining authorization to repurchase up to $ 1,013 million of its common stock under the Repurchase Program. In addition, from time to time, the Company has repurchased and may continue to rep... | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
The portion of goodwill deductible for income tax purposes was preliminarily assessed as $ 343 million and $ 379 million for the years ended December 31, 2024 and 2023, respectively. | text | 343 | monetaryItemType | text: <entity> 343 </entity> <entity type> monetaryItemType </entity type> <context> The portion of goodwill deductible for income tax purposes was preliminarily assessed as $ 343 million and $ 379 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount |
The portion of goodwill deductible for income tax purposes was preliminarily assessed as $ 343 million and $ 379 million for the years ended December 31, 2024 and 2023, respectively. | text | 379 | monetaryItemType | text: <entity> 379 </entity> <entity type> monetaryItemType </entity type> <context> The portion of goodwill deductible for income tax purposes was preliminarily assessed as $ 343 million and $ 379 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount |
The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 67 | monetaryItemType | text: <entity> 67 </entity> <entity type> monetaryItemType </entity type> <context> The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, ... | us-gaap:RestructuringCharges |
The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 84 | monetaryItemType | text: <entity> 84 </entity> <entity type> monetaryItemType </entity type> <context> The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, ... | us-gaap:RestructuringCharges |
The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, ... | us-gaap:RestructuringCharges |
The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of ... | text | 18.0 | percentItemType | text: <entity> 18.0 </entity> <entity type> percentItemType </entity type> <context> The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to th... | us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent |
The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of ... | text | 6.9 | percentItemType | text: <entity> 6.9 </entity> <entity type> percentItemType </entity type> <context> The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the... | us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent |
The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of ... | text | 19.1 | percentItemType | text: <entity> 19.1 </entity> <entity type> percentItemType </entity type> <context> The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to th... | us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent |
The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of ... | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the... | us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic |
Undistributed earnings of the Company’s foreign subsidiaries amounted to approximately $ 5,117 million as of December 31, 2024. The Company does not consider any of its foreign earnings as indefinitely reinvested. | text | 5117 | monetaryItemType | text: <entity> 5117 </entity> <entity type> monetaryItemType </entity type> <context> Undistributed earnings of the Company’s foreign subsidiaries amounted to approximately $ 5,117 million as of December 31, 2024. The Company does not consider any of its foreign earnings as indefinitely reinvested. </context> | us-gaap:UndistributedEarningsOfForeignSubsidiaries |
In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury published final regulations related to foreign currency gains and losses that are ef... | text | 30 | monetaryItemType | text: <entity> 30 </entity> <entity type> monetaryItemType </entity type> <context> In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury ... | us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease |
In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury published final regulations related to foreign currency gains and losses that are ef... | text | 196 | monetaryItemType | text: <entity> 196 </entity> <entity type> monetaryItemType </entity type> <context> In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury... | us-gaap:DeferredTaxAssetsValuationAllowance |
In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury published final regulations related to foreign currency gains and losses that are ef... | text | 166 | monetaryItemType | text: <entity> 166 </entity> <entity type> monetaryItemType </entity type> <context> In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury... | us-gaap:DeferredTaxAssetsValuationAllowance |
As of December 31, 2024, the Company had total gross unrecognized income tax benefits of $ 132 million associated with over 100 jurisdictions in which the Company conducts business that, if recognized, would reduce the Company’s effective income tax rate. | text | 132 | monetaryItemType | text: <entity> 132 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had total gross unrecognized income tax benefits of $ 132 million associated with over 100 jurisdictions in which the Company conducts business that, if recognized, would reduce the Company’s effect... | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company’s policy for recording interest and penalties relating to uncertain income tax positions is to record them as a component of income tax expense in the accompanying consolidated statements of income. In the years ended December 31, 2024, 2023 and 2022, the amount of interest and penalties recorded as an addi... | text | 26 | monetaryItemType | text: <entity> 26 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s policy for recording interest and penalties relating to uncertain income tax positions is to record them as a component of income tax expense in the accompanying consolidated statements of income. In the years ended Decemb... | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The Company’s policy for recording interest and penalties relating to uncertain income tax positions is to record them as a component of income tax expense in the accompanying consolidated statements of income. In the years ended December 31, 2024, 2023 and 2022, the amount of interest and penalties recorded as an addi... | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s policy for recording interest and penalties relating to uncertain income tax positions is to record them as a component of income tax expense in the accompanying consolidated statements of income. In the years ended Decemb... | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The Company believes that it is reasonably possible that a decrease of up to $ 8 million in gross unrecognized income tax benefits for federal, state and foreign exposure items may be necessary within the next 12 months due to lapse of statutes of limitations or uncertain tax positions being effectively settled. The Co... | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> The Company believes that it is reasonably possible that a decrease of up to $ 8 million in gross unrecognized income tax benefits for federal, state and foreign exposure items may be necessary within the next 12 months due to lapse of s... | us-gaap:UnrecognizedTaxBenefits |
The Company believes that it is reasonably possible that a decrease of up to $ 8 million in gross unrecognized income tax benefits for federal, state and foreign exposure items may be necessary within the next 12 months due to lapse of statutes of limitations or uncertain tax positions being effectively settled. The Co... | text | 13 | monetaryItemType | text: <entity> 13 </entity> <entity type> monetaryItemType </entity type> <context> The Company believes that it is reasonably possible that a decrease of up to $ 8 million in gross unrecognized income tax benefits for federal, state and foreign exposure items may be necessary within the next 12 months due to lapse of ... | us-gaap:UnrecognizedTaxBenefits |
The Company expects to contribute approximately $ 30 million in required contributions to its pension and postretirement benefit plans during 2025. The Company may make additional contributions into its pension plans in 2025 depending on, among other factors, how the funded status of those plans change or in order to m... | text | 30 | monetaryItemType | text: <entity> 30 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to contribute approximately $ 30 million in required contributions to its pension and postretirement benefit plans during 2025. The Company may make additional contributions into its pension plans in 2025 depending o... | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Company expensed $ 80 million, $ 81 million and $ 74 million, respectively, related to ma... | text | 80 | monetaryItemType | text: <entity> 80 </entity> <entity type> monetaryItemType </entity type> <context> In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Compa... | us-gaap:DefinedContributionPlanCostRecognized |
In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Company expensed $ 80 million, $ 81 million and $ 74 million, respectively, related to ma... | text | 81 | monetaryItemType | text: <entity> 81 </entity> <entity type> monetaryItemType </entity type> <context> In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Compa... | us-gaap:DefinedContributionPlanCostRecognized |
In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Company expensed $ 80 million, $ 81 million and $ 74 million, respectively, related to ma... | text | 74 | monetaryItemType | text: <entity> 74 </entity> <entity type> monetaryItemType </entity type> <context> In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Compa... | us-gaap:DefinedContributionPlanCostRecognized |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income.... | text | 206 | monetaryItemType | text: <entity> 206 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, gener... | us-gaap:ShareBasedCompensation |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income.... | text | 217 | monetaryItemType | text: <entity> 217 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, gener... | us-gaap:ShareBasedCompensation |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income.... | text | 194 | monetaryItemType | text: <entity> 194 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, gener... | us-gaap:ShareBasedCompensation |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income.... | text | 36 | monetaryItemType | text: <entity> 36 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, genera... | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income.... | text | 34 | monetaryItemType | text: <entity> 34 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, genera... | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income.... | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, genera... | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income.... | text | 215 | monetaryItemType | text: <entity> 215 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, gener... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
As of December 31, 2024, there were 7.6 million shares available for future grants under all of the Company’s stock incentive plans. | text | 7.6 | sharesItemType | text: <entity> 7.6 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there were 7.6 million shares available for future grants under all of the Company’s stock incentive plans. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The weighted average fair value per share of SSRs granted in the year ended December 31, 2024 was $ 70.63 . The total intrinsic value of SSRs exercised was approximately $ 88 million, $ 51 million and $ 25 million in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 70.63 | perShareItemType | text: <entity> 70.63 </entity> <entity type> perShareItemType </entity type> <context> The weighted average fair value per share of SSRs granted in the year ended December 31, 2024 was $ 70.63 . The total intrinsic value of SSRs exercised was approximately $ 88 million, $ 51 million and $ 25 million in the years ended ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised... | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 m... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised... | text | 23 | monetaryItemType | text: <entity> 23 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 m... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised... | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 mi... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised... | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 mi... | us-gaap:ProceedsFromStockOptionsExercised |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised... | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 mi... | us-gaap:ProceedsFromStockOptionsExercised |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised... | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 mi... | us-gaap:ProceedsFromStockOptionsExercised |
The weighted average remaining contractual life of the options outstanding and exercisable as of December 31, 2024 is 1.0 years. The total aggregate intrinsic value of the exercisable stock options as of December 31, 2024 was approximately $ 11 million. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> The weighted average remaining contractual life of the options outstanding and exercisable as of December 31, 2024 is 1.0 years. The total aggregate intrinsic value of the exercisable stock options as of December 31, 2024 was approximat... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue |
As of December 31, 2024, there are 992,478 performance awards outstanding with an intrinsic value of approximately $ 195 million. | text | 992478 | sharesItemType | text: <entity> 992478 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there are 992,478 performance awards outstanding with an intrinsic value of approximately $ 195 million. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
As of December 31, 2024, there are 992,478 performance awards outstanding with an intrinsic value of approximately $ 195 million. | text | 195 | monetaryItemType | text: <entity> 195 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there are 992,478 performance awards outstanding with an intrinsic value of approximately $ 195 million. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding |
The Company’s RSUs will settle in shares of the Company’s common stock within 30 days of the applicable vesting date. In general, RSUs granted to employees vest either (i) one-third per year beginning on the first anniversary of the grant date or (ii) 100 % at the end of the three-year period following the grant date. ... | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company’s RSUs will settle in shares of the Company’s common stock within 30 days of the applicable vesting date. In general, RSUs granted to employees vest either (i) one-third per year beginning on the first anniversary of the gra... | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
(1) Pursuant to the IQVIA Holdings Inc. Non-Employee Director Deferral Plan (the “Director Deferral Plan”), non-employee directors may elect to defer receipt of their cash and/or equity retainers. If a director elects to defer his or her retainer, he or she will instead be credited with that value in deferred shares un... | text | 6482 | sharesItemType | text: <entity> 6482 </entity> <entity type> sharesItemType </entity type> <context> (1) Pursuant to the IQVIA Holdings Inc. Non-Employee Director Deferral Plan (the “Director Deferral Plan”), non-employee directors may elect to defer receipt of their cash and/or equity retainers. If a director elects to defer his or he... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
As of December 31, 2024, there are 1,000,328 RSUs outstanding with an intrinsic value of approximately $ 197 million. | text | 1000328 | sharesItemType | text: <entity> 1000328 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there are 1,000,328 RSUs outstanding with an intrinsic value of approximately $ 197 million. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
As of December 31, 2024, there are 1,000,328 RSUs outstanding with an intrinsic value of approximately $ 197 million. | text | 197 | monetaryItemType | text: <entity> 197 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there are 1,000,328 RSUs outstanding with an intrinsic value of approximately $ 197 million. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respective... | text | 109.83 | perShareItemType | text: <entity> 109.83 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respective... | text | 152.17 | perShareItemType | text: <entity> 152.17 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respective... | text | 147.41 | perShareItemType | text: <entity> 147.41 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respective... | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to se... | us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respective... | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to s... | us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respective... | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to se... | us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards |
The Company’s cash settled RSUs (“Cash RSUs”) require the Company to settle in cash an amount equal to the fair value of the Company’s common stock on the vest date multiplied by the number of vested Cash RSUs. These awards vest either (i) 100 % at the end of the | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company’s cash settled RSUs (“Cash RSUs”) require the Company to settle in cash an amount equal to the fair value of the Company’s common stock on the vest date multiplied by the number of vested Cash RSUs. These awards vest either ... | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
-year period following the date of grant, or (ii) one-third per year beginning on the first grant date anniversary. As of December 31, 2024, there are 5,808 Cash RSUs outstanding with an intrinsic value of approximately $ 1 million. | text | 5808 | sharesItemType | text: <entity> 5808 </entity> <entity type> sharesItemType </entity type> <context> -year period following the date of grant, or (ii) one-third per year beginning on the first grant date anniversary. As of December 31, 2024, there are 5,808 Cash RSUs outstanding with an intrinsic value of approximately $ 1 million. </c... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber |
-year period following the date of grant, or (ii) one-third per year beginning on the first grant date anniversary. As of December 31, 2024, there are 5,808 Cash RSUs outstanding with an intrinsic value of approximately $ 1 million. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> -year period following the date of grant, or (ii) one-third per year beginning on the first grant date anniversary. As of December 31, 2024, there are 5,808 Cash RSUs outstanding with an intrinsic value of approximately $ 1 million. </co... | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding |
During the year ended December 31, 2022, the Company entered into long term incentive award agreements with certain employees totaling a fixed monetary amount of $ 80 million to issue a variable number of common shares based on the fair market value when the awards vest on the third anniversary of the grant date. The C... | text | 26 | monetaryItemType | text: <entity> 26 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, the Company entered into long term incentive award agreements with certain employees totaling a fixed monetary amount of $ 80 million to issue a variable number of common shares based on the fair... | us-gaap:ShareBasedCompensation |
During the year ended December 31, 2022, the Company entered into long term incentive award agreements with certain employees totaling a fixed monetary amount of $ 80 million to issue a variable number of common shares based on the fair market value when the awards vest on the third anniversary of the grant date. The C... | text | 22 | monetaryItemType | text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, the Company entered into long term incentive award agreements with certain employees totaling a fixed monetary amount of $ 80 million to issue a variable number of common shares based on the fair... | us-gaap:ShareBasedCompensation |
The following table presents the Company’s operations by reportable segment. The Company is managed through three reportable segments, Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, techno... | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> The following table presents the Company’s operations by reportable segment. The Company is managed through three reportable segments, Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Sol... | us-gaap:NumberOfReportableSegments |
For the years ended December 31, 2024, 2023 and 2022 the weighted average number of outstanding stock-based awards not included in the computation of diluted earnings per share because they are subject to performance conditions that have not been met at the end of the reporting period or the effect of including such st... | text | 1.0 | sharesItemType | text: <entity> 1.0 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022 the weighted average number of outstanding stock-based awards not included in the computation of diluted earnings per share because they are subject to performance conditions that have... | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2024, 2023 and 2022 the weighted average number of outstanding stock-based awards not included in the computation of diluted earnings per share because they are subject to performance conditions that have not been met at the end of the reporting period or the effect of including such st... | text | 0.5 | sharesItemType | text: <entity> 0.5 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022 the weighted average number of outstanding stock-based awards not included in the computation of diluted earnings per share because they are subject to performance conditions that have... | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
The Consolidated Financial Statements include all wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The Company participates in two joint ventures that have been consolidated in accordance with the consolidation accounting guidance. An analysis is performed to deter... | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> The Consolidated Financial Statements include all wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The Company participates in two joint ventures that have been consolidated in accor... | us-gaap:EquityMethodInvestmentOwnershipPercentage |
Inventories are stated at the lower of cost or market value. Approximately 45 % of total net inventory value is determined utilizing the last-in, first-out (LIFO) method of inventory accounting. The cost of foreign inventories and certain domestic inventories is determined utilizing average cost or first-in, first-out ... | text | 45 | percentItemType | text: <entity> 45 </entity> <entity type> percentItemType </entity type> <context> Inventories are stated at the lower of cost or market value. Approximately 45 % of total net inventory value is determined utilizing the last-in, first-out (LIFO) method of inventory accounting. The cost of foreign inventories and certai... | us-gaap:PercentageOfLIFOInventory |
Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitalized computer software is for internal use and costs primarily consist of purchased ma... | text | 6.3 | monetaryItemType | text: <entity> 6.3 </entity> <entity type> monetaryItemType </entity type> <context> Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitali... | us-gaap:CapitalizedComputerSoftwareNet |
Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitalized computer software is for internal use and costs primarily consist of purchased ma... | text | 5.8 | monetaryItemType | text: <entity> 5.8 </entity> <entity type> monetaryItemType </entity type> <context> Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitali... | us-gaap:CapitalizedComputerSoftwareNet |
Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitalized computer software is for internal use and costs primarily consist of purchased ma... | text | 3.6 | monetaryItemType | text: <entity> 3.6 </entity> <entity type> monetaryItemType </entity type> <context> Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitali... | us-gaap:CapitalizedComputerSoftwareAmortization1 |
Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitalized computer software is for internal use and costs primarily consist of purchased ma... | text | 4.3 | monetaryItemType | text: <entity> 4.3 </entity> <entity type> monetaryItemType </entity type> <context> Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitali... | us-gaap:CapitalizedComputerSoftwareAmortization1 |
Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitalized computer software is for internal use and costs primarily consist of purchased ma... | text | 6.6 | monetaryItemType | text: <entity> 6.6 </entity> <entity type> monetaryItemType </entity type> <context> Capitalized computer software costs, net of amortization, were $ 6.3 million and $ 5.8 million at December 31, 2024 and 2023, respectively. This balance is reflected in Other long-term assets in the Consolidated Balance Sheet. Capitali... | us-gaap:CapitalizedComputerSoftwareAmortization1 |
The Company has ongoing agreements with financial institutions to facilitate the processing of vendor payables (“Payment Services Arrangement”). Under these agreements, the Company pays the financial institution the stated amount of confirmed invoices from participating suppliers on their original maturity date. The te... | text | 101.9 | monetaryItemType | text: <entity> 101.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company has ongoing agreements with financial institutions to facilitate the processing of vendor payables (“Payment Services Arrangement”). Under these agreements, the Company pays the financial institution the stated amount of ... | us-gaap:SupplierFinanceProgramObligationCurrent |
The Company has ongoing agreements with financial institutions to facilitate the processing of vendor payables (“Payment Services Arrangement”). Under these agreements, the Company pays the financial institution the stated amount of confirmed invoices from participating suppliers on their original maturity date. The te... | text | 101.3 | monetaryItemType | text: <entity> 101.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company has ongoing agreements with financial institutions to facilitate the processing of vendor payables (“Payment Services Arrangement”). Under these agreements, the Company pays the financial institution the stated amount of ... | us-gaap:SupplierFinanceProgramObligationCurrent |
In 2021, the Company entered into an agreement with a financial institution that allows participating suppliers to receive payment for outstanding invoices through a commercial purchasing card sponsored by a financial institution. The Company is required to settle such outstanding invoices through a consolidated paymen... | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> In 2021, the Company entered into an agreement with a financial institution that allows participating suppliers to receive payment for outstanding invoices through a commercial purchasing card sponsored by a financial institution. The ... | us-gaap:SupplierFinanceProgramObligationCurrent |
In 2021, the Company entered into an agreement with a financial institution that allows participating suppliers to receive payment for outstanding invoices through a commercial purchasing card sponsored by a financial institution. The Company is required to settle such outstanding invoices through a consolidated paymen... | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> In 2021, the Company entered into an agreement with a financial institution that allows participating suppliers to receive payment for outstanding invoices through a commercial purchasing card sponsored by a financial institution. The ... | us-gaap:SupplierFinanceProgramObligationCurrent |
On February 1, 2022, the Company completed the sale of the C&I Lighting business to GE Current, a Daintree Company, for total net cash consideration of $ 332.8 million. We have concluded the divestiture of this business represents a strategic shift that will have a major effect on our operations and financial results, ... | text | 332.8 | monetaryItemType | text: <entity> 332.8 </entity> <entity type> monetaryItemType </entity type> <context> On February 1, 2022, the Company completed the sale of the C&I Lighting business to GE Current, a Daintree Company, for total net cash consideration of $ 332.8 million. We have concluded the divestiture of this business represents a ... | us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested |
Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase in current year deferrals primarily due to timing of advance payments on certain orde... | text | 148.0 | monetaryItemType | text: <entity> 148.0 </entity> <entity type> monetaryItemType </entity type> <context> Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increas... | us-gaap:ContractWithCustomerLiability |
Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase in current year deferrals primarily due to timing of advance payments on certain orde... | text | 118.6 | monetaryItemType | text: <entity> 118.6 </entity> <entity type> monetaryItemType </entity type> <context> Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increas... | us-gaap:ContractWithCustomerLiability |
Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase in current year deferrals primarily due to timing of advance payments on certain orde... | text | 29.4 | monetaryItemType | text: <entity> 29.4 </entity> <entity type> monetaryItemType </entity type> <context> Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase... | us-gaap:IncreaseDecreaseInContractWithCustomerLiability |
Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase in current year deferrals primarily due to timing of advance payments on certain orde... | text | 108.3 | monetaryItemType | text: <entity> 108.3 </entity> <entity type> monetaryItemType </entity type> <context> Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increas... | us-gaap:IncreaseDecreaseInDeferredCharges |
Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase in current year deferrals primarily due to timing of advance payments on certain orde... | text | 78.9 | monetaryItemType | text: <entity> 78.9 </entity> <entity type> monetaryItemType </entity type> <context> Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase... | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase in current year deferrals primarily due to timing of advance payments on certain orde... | text | 38.0 | monetaryItemType | text: <entity> 38.0 </entity> <entity type> monetaryItemType </entity type> <context> Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase... | us-gaap:ContractWithCustomerAssetNetCurrent |
Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase in current year deferrals primarily due to timing of advance payments on certain orde... | text | 41.6 | monetaryItemType | text: <entity> 41.6 </entity> <entity type> monetaryItemType </entity type> <context> Contract liabilities were $ 148.0 million as of December 31, 2024 compared to $ 118.6 million as of December 31, 2023. The $ 29.4 million increase in our contract liabilities balance was primarily due to a $ 108.3 million net increase... | us-gaap:ContractWithCustomerAssetNetCurrent |
The Company has elected the practical expedient to disclose only the value of unsatisfied performance obligations for contracts with an original expected length greater than one year. As of December 31, 2024, the Company had approximately $ 70 million of unsatisfied performance obligations for contracts with an origin... | text | 70 | monetaryItemType | text: <entity> 70 </entity> <entity type> monetaryItemType </entity type> <context> The Company has elected the practical expedient to disclose only the value of unsatisfied performance obligations for contracts with an original expected length greater than one year. As of December 31, 2024, the Company had approximat... | us-gaap:RevenueRemainingPerformanceObligation |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.